HCAHCA Healthcare

1. Jul 29, 2026On July 29, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), increased the size of its commercial paper program under which the Issuer may issue unsecured commercial paper notes (the “Notes”) from time to time from a maximum aggregate face or principal …New debt or off-balance-sheet obligation · Form 8-K
2. Jul 24, 2026On July 24, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock.Earnings release · Form 8-K
3. Jul 14, 2026HCA Healthcare PREVIEWS SECOND quarter 2026 results.Earnings release · press release
4. Jun 18, 2026On June 15, 2026, Dr. Michael Cuffe and HCA Healthcare, Inc. (the “Company”) agreed that Dr. Cuffe will step down as Executive Vice President and Chief Clinical Officer effective August 31, 2026, and thereafter continue in a transitional role with the Company until February 2027.Director or officer change · Form 8-K
5. Apr 30, 2026Issuance of $3,000,000,000 aggregate principal amount of senior notes Overview On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due …Material agreement entered · Form 8-K
6. Apr 27, 2026On April 27, 2026, HCA Healthcare, Inc. (the “Registrant”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes (the “Offering”)Other event · Form 8-K
7. Apr 24, 2026On April 24, 2026, the Company announced that its Board of Directors had declared a quarterly cash dividend of $0.78 per share of the Company’s common stock.Earnings release · Form 8-K
8. Feb 25, 20262026 Executive Officer Performance Excellence Program On February 24, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HCA Healthcare, Inc. (the “Company”) adopted the 2026 Executive Officer Performance Excellence Program (the “Executive Officer PEP”)Director or officer change · Form 8-K
9. Jan 27, 2026On January 27, 2026, the Company announced that its Board of Directors had authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock.Earnings release · Form 8-K
10. Oct 31, 2025Issuance of $3,250,000,000 aggregate principal amount of senior notes Overview On October 31, 2025, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $500,000,000 aggregate principal amount of its 4.300% Senior Notes due …Material agreement entered · Form 8-K
11. Oct 27, 2025On October 27, 2025, HCA Healthcare, Inc. (the “Registrant”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Registrant, of senior unsecured notes (the “Offering”)Other event · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.